INTRODUCTION
Stock market investments are risky, even when based on reliable information. But when such investments are based on downright fraudulent information, the investments can be ruinous. Around the turn of the century, investor confidence in the securities exchanges waned amidst reports of corporate fraud.' In one instance, investors lost billions because they relied on the fraudulent public statements of a single company-WorldCom, Inc.
2 A corporation's fraudulent public statements, which are made to induce investment, can expose corporations to liability from both private investors and the Securities and Exchange Commission (SEC).3 But what happens when the corporation that made those statements is bankrupt and piercing the corporate veil is not a viable option?
4 Do private investors have recourse against any other entities such as the securities exchanges through which the investors purchased the stock? In other words, may public statements made by a securities exchange 5 expose the exchange to liability? Usually, when private investors lose their shirts because of bad stock-market information and look for someone to sue, self-regulatory organizations (SROs) 6 are not an option. SROs are entities designated by the SEC either as national securities exchanges, such as the National Association of Securities Dealers Automated Quotations I See, e.g., Adam C. Pritchard, Self-Regulation and Securities Markets, REGULATION, Spring 2003, at 32 ("Today, many investors are rethinking the wisdom of entrusting their financial futures to the stock market. Absent trust in the integrity of the securities markets, individuals will hoard their money under the proverbial mattress.").
2 See Daniel Kadlec, Next: WorldCom's $11 Billion Case, TIME, Mar. 15, 2004 , at 66 (noting that WorldCom's former chief, Bernard Ebbers, masterminded an accounting fraud estimated near $11 billion, and caused investors to lose $180 billion-"three times the amount of wealth destroyed at Enron").
-3 See, e.g., STONERIDGE IN-v. PARTNERS V. SCIENTIFIC-ATLANTA, Inc., No. 06-43, slip op. at 5-6 (U.S. Jan. 15, 2008) (discussing liability under § 10(b) of the Securities Exchange Act of 1934 and noting that such liability does not extend to aiders and abettors).
4 The "corporate veil" refers to the separation, for liability purposes, of the corporation from the shareholders who own it: the shareholders may not be held liable in their personal capacity unless the veil is pierced, which may occur in exceptional circumstances of fraud. See, e.g., DOLE FOOD Co. V. PATRICKSON, 538 U.S. 468, 474-76 (2003) .
5 See 15 U.S.C. § 78c(a)(1) (2006) ("The term 'exchange' means any organization, association, or group of persons, whether incorporated or unincorporated, which constitutes, maintains, or provides a market place or facilities for bringing together purchasers and sellers of securities or for otherwise performing with respect to securities the functions commonly performed by a stock exchange as that term is generally understood, and includes the market place and the market facilities maintained by such exchange."). For further elaboration on the definition, see 17 C.F.R. § 240. 3b-16 (2008) .
6 See 15 U.S.C. § 78c(a) (26) ("The term 'self-regulatory organization' means any national securities exchange, registered securities association, or registered clearing agency ....").
(NASDAQ) and the New York Stock Exchange 7 (NYSE), or as registered securities associations, such as the National Association of Securities Dealers 8 (NASD). SROs are self-regulating, self-disciplining, 9 quasi-governmental entities that serve the important governmental purpose of providing a fair market for securities trading. 10 These organizations are granted absolute immunity from private lawsuits because of these characteristics, so long as the activity in question is within the quasi-governmental authority delegated by the SEC. 1 But the scope of that authority may be shrinking in a way that makes it possible for private investors to sue the SROs for investments gone awry.
On September 18, 2007, the Eleventh Circuit, sitting en banc, handed down a decision that severely limits the scope of absolute immunity for SROs. In Weissran v. National Association of Securities Dealers, the court found that a private investor could sue the NASD and NASDAQ to recover from a disastrous investment in WorldCom because the investor allegedly relied on the SROs' public statements-in particular, two advertisements that had purportedly touted WorldCom as a sound investment. 12 The court denied NASD and NASDAQ's motion to dismiss based on absolute immunity because the defendants issued the advertisements in their private, for-profit capacity-not in their quasi-governmental capacity-and were thus subject to liability. 13 Two strong dissents shredded the majority opinion: one dissent argued in part that one of the two advertisements was indeed part of the SROs' quasi-governmental authority to regulate because NASDAQ was simply disseminating its listing requirements, 14 [S] tock exchanges perform an important role to provide for fair trading and accurate price discovery, both critical components in fostering investor confidence.").
11
See, e.g., D'Alessio v. NYSE, 258 F.3d 93, 105 (2d. Cir. 2001) ("The NYSE, as a SRO, stands in the shoes of the SEC in interpreting the securities laws for its members and in monitoring compliance with those laws. It follows that the NYSE should be entitled to the same immunity enjoyed by the SEC when it is performing functions delegated to it under the SEC's broad oversight authority.").
12 500 F.3d 1293, 1294-99 (11th Cir. 2007).
13 Id . at 1299
14 Id. at 1301-02 (Pryor, J., concurring in part and dissenting in part) (arguing that a particular Wall Street Journal advertisement should be covered by absolute immunity but that a particular television ad should not). For a description of the advertisements in question, see infra Part II. the other dissent argued in part that the majority fell victim to artful pleading. 15 This Note analyzes Weissman and its implications, particularly for two other cases in which SROs made public statements that threatened to expose them to liability. First, in In re NYSE Specialists Securities Litigation (a case the Second Circuit decided on the same day that the Eleventh Circuit decided Weissman), the NYSE made statements attesting to the quality of its oversight while allegedly simultaneously ignoring and encouraging fraudulent activities on its trading floors. 16 Although the Second Circuit upheld the NYSE's absolute immunity for its regulatory actions, 17 the court remanded to determine whether the NYSE could be liable in a private capacity if investors relied on NYSE's public misstatements. 18 The Eleventh Circuit's Weissman analysis is likely to play a role in the decision on remand.
The second absolute immunity case that Weissman affects is Opulent Fund v. NASDAQ Stock Market, 19 in which the Northern District of California denied NASDAQ absolute immunity for public statements that announced the price of its NASDAQ-100 Index. The plaintiff, Opulent, claimed that a particular price announcement was in error, resulting in significant losses on Opulent's options portfolios. 20 The court quoted heavily from Weissman in denying NASDAQ absolute immunity for announcing the price of its Index, an activity the court characterized as facilitating the trading of derivatives. 21 Such a characterization meant that announcing that day's price was not considered one of NASDAQ's regulatory activities, but rather one of its private, for-profit activities, and thus was not immune from private suit. 22 Building on Weissman, the Opulent Fund decision further limits what activities are considered "regulatory."
In this Note I argue that an SRO's regulatory authority should be viewed broadly at the pleadings' stage so as not to unduly narrow the scope of SRO absolute immunity; that an SRO's public statements should normally fall under its regulatory authority; and that an unduly narrow view of that authority will chill SRO media communications. Part I provides a brief history of SROs in the United States and describes how the self-regulatory authority that the SEC grants SROs leads to absolute immunity. Part II summarizes Weissman and the two cases it immediately affected. Part III examines several of Weissman's negative implications, particularly how the decision defeats the very purpose of absolute immunity-to shield officials performing governmental functions from the distractions of recriminatory litigation-by allowing plaintiffs to plead reliance solely on the SRO's for-profit capacity. Part III also offers a way to limit Weissman's negative implications by suggesting a tentative solution: when SROs make public statements, absolute immunity should only be withheld if the SRO has recommended a particular course of investment. With this suggestion, I hope to encourage courts to adopt a test for whether an SRO has implicitly recommended an investment; I also offer factors as a starting point for courts to apply such a test. 27 This ease of transfer means that the 23 In the SRO context, a "member" essentially means anyone permitted to directly make transactions on the trading floor and any broker or dealer. See 15 U.S.C. § 78c(a)(3)(A) (2006) ("The term 'member' when used with respect to a national securities exchange means (i) any natural person permitted to effect transactions on the floor of the exchange without the services of another person acting as broker, (ii) any registered broker or dealer with which such a natural person is associated, (iii) any registered broker or dealer permitted to designate as a representative such a natural person, and (iv) any other registered broker or dealer which agrees to be regulated by such exchange .... ). Dec. 20, 2007 , at 3 (explaining that the government has at times exploited SRO scandals to impose government reform and oversight, converting SROs from "private clubs" to public bodies).
I
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SROs provide liquidity to investors in three ways: (1) they bring willing investors together with corporations in need of investment capital; (2) they allow investors to reduce their risk by diversifying their portfolios; and (3) they allow investors to move in and out of an investment efficiently enough that the price does not fluctuate significantly. 28 The second function that SROs perform is to regulate both their own markets and their members. 29 This regulatory function consists of promulgating and enforcing the SROs' own rules and also enforcing the SEC-created federal securities laws. 30 Thus, all who trade on an SRO's exchange are subject to the SRO's rules and the federal laws that SROs are entrusted to enforce. 3 1 The SROs have broad authority to discipline violations of rule or law, including the power to fine or ban the violating member.
32
Self-regulation of the securities industry is not a new phenomenon; American securities exchanges have been regulating their own markets and members since their advent. 33 The NYSE was founded in 1792 as one of the earliest securities exchanges. 34 By the mid-1930s, up to twenty-one different exchanges existed in the United States with little or no governmental oversight 35 -interestingly, this lack of governmental regulation is sometimes said to have been a primary cause of the Great Depression. 36 Nevertheless, the exchanges maintained 28 Fleckner, supra note 10, at 2546. For a discussion of how the dual nature of SROs-that of regulator and market competitor-creates an inherent conflict of interest, and will inevitably lead to problems of under-and overregulation, see id. at 2579-80, 2593-97.
29 Id. at 2547-48. 30 Badway & Busch, supra note 7, at 1352. 31 Fleckner, supra note 10, at 2547 ("All market participants and affiliates, particularly the broker-dealers that trade on the market and the issuers of the traded shares, are subject to rules that stock exchanges enact particularly for their marketplace. Moreover, stock exchanges are empowered to monitor the participants' compliance with the regulatory regime, not only with respect to their own rules but also with federal and state law and rules promulgated thereunder, most importantly by the SEC."). The problems inherent in the exchanges having superior information over the average investor have not been left in the past. The economic value of the kind of data that stock exchanges offer often leads to securities fraud, such as insider trading and market manipulation. As a primary example, information on recently executed trades, such as volume and parties involved, is critical to analyzing the market and deciding whether to that they should remain private and that the vast infrastructure they used to self-regulate was superior to a bureaucratic regime.
3 7 This tension resulted in the Securities Exchange Act of 1934, which was, at bottom, a compromise between Congress and the exchanges. The Securities Exchange Act of 1934 (the Exchange Act) was largely a result of Congress's increased awareness of "unchecked speculator fraud" and the importance of securities exchanges to the nation's economy. 39 The Exchange Act sought primarily to protect investors from then-common abuses by reining in the exchanges' ability to manipulate stock quotes and trading information. 40 In essence, it codified the self-regulatory regime that the exchanges sought to maintain but provided for SEC oversight. 41 Each SRO would be independently responsible for enforcing its own rules as well as the federal securities laws, 42 but the SEC would serve as a "watch-dog government agency" to ensure such enforcement was done properly. 43 Under the Exchange Act, the securities exchanges are self-regulatory. 44 This means that they are responsible for promulgating rules, monitoring their members' conduct, and disciplining their own members. 45 SROs are thus legally obligated to regulate themselves, 46 but the rules that the SROs set forth are subject to SEC approval. 47 Though the SEC retains oversight, SROs maintain their quasi-governmental status because they perform the kind of regulatory tasks that the SEC would otherwise have to undertake. 48 buy or sell. See Fleckner, supra note 10, at 2547. Also, for the derivatives market-a market for financial instruments such as stock options, whose value depends on the price of the stock-sound business decisions require up-to-the-minute stock prices. See id. Another example is information on stock quotes-offers to buy and sell at a particular price-which provide a means for predicting future stock price. See id. Both information on past trades and stock quotes serve essential regulatory functions as well, because the same information is needed to detect the fraud as is needed to commit it. See id.
37
Cf Badway & Busch, supra note 7, at 1352 (noting that, by 1934, each exchange relied "on the premise that markets are best left to regulate themselves"). One of the biggest changes that the Exchange Act effected was to require all national exchanges to register with the SEC and abide by the obligations that it imposed. 49 The SEC has the authority to deny an SRO's registration if the SEC finds that the SRO's rules do not sufficiently guard against fraud, promote equitable trading, or provide for discipline in the event of a violation.
5 0 Moreover, the SEC has the ability to enforce compliance with the Exchange Act 51 and prevent fraudulent and manipulative practices among the SRO's members.
52
C. The Advantages of Self-Regulation Congress's rationale for permitting SROs to continue to regulate themselves (and the SROs' willingness to regulate themselves) stems from a number of perceived benefits of minimal government regulation. First, self-regulation may provide a cost-effective and efficient method of supervising the markets that the government simply could not provide.
5 3 The bureaucratic redundancies inherent in complete government supervision would stifle the fast-paced securities industry, 54 which responds minute-by-minute to fluctuations in the market. Second, SROs may be better equipped than a government agency to respond quickly to the highly technical regulatory problems in today's market. 5 5 Third, SRO self-regulation means that taxpayers do not bear the additional burden that government regulation of the securities markets would entail. 5 6 Similarly, SROs can use the industry's own funding to regulate, 57 which may be more robust and better focused than government funding. Finally (and perhaps most importantly), self-regulating SROs are not subject to the same legal constraints that a government agency would be-namely the Consti- 49 Id. 50
Id. at 1353-54.
51
15 U.S.C. § 78f(b)(1).
52
Id. § 78f(b), (b) (5) ("An exchange shall not be registered as a national securities exchange unless the Commission determines that . . . [t]he rules of the exchange are designed to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade,... to remove impediments to and perfect the mechanism of a free and open market and a national market system, and, in general, to protect investors and the public interest . . ").
53
Badway & Busch, supra note 7, at 1362. 54 See id. 56 Badway & Busch, supra note 7, at 1362-63; Richards, supra note 55 (explaining that the securities industry's financing of its own regulation reduces the cost to all taxpayers).
57
Cf Fleckner, supra note 10, at 2586 (stating that the NYSE employs over seven hundred people for regulatory issues).
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D. The Disadvantages of Self-Regulation
Despite the above-mentioned arguments, self-regulation has also been significantly criticized. First, although SROs have traditionally been created as not-for-profit organizations, increasing economic pressures have forced them to move toward demutualization-the process of restructuring an organization to become publicly traded, for-profit entities. 60 As SROs moved closer to for-profit status, many commentators called for changes to the self-regulatory regime. 61 The conflicts of interest inherent in an entity's attempts to maximize profits while regulating itself are undeniable. 60 Fleckner, suptra note 10, at 2541-42 (explaining that demutualization is largely the product of domestic and international competition). Several other factors also brought on this trend. First, technology improvements now allow for more efficient trades that eliminate the middleman dealer. See Dombalagian, supra note 8, at 331-33. Second, recent SEC requirements-that the SRO's regulatory function be separate from its operational function-have allowed SROs to operate as for-profit subsidiaries. See id. at 333. Further, for-profit structures have allowed SROs to raise money for technology advances through public offerings instead of raising regulatory and trading fees, which would have drawn increased SEC scrutiny. See id. at 334.
61 Cf Fleckner, supra note 10, at 2579-2618 (identifying conflicts of interest created by demutualization and proposing amendments that would mitigate the conflicts of interest that stem from going public). See generally Badway & Busch, supra note 7 (suggesting that a "new and improved" SEC should undertake all investigative, policing, and enforcement matters); Dombalagian, supra note 36, at 1146-48 (proposing a modified framework that reallocates some self-regulatory responsibilities from exchanges to a representative set of market participants).
62 See Badway & Busch, supra note 7, at 1352 ("SROs are charged with the responsibility of protecting investors and fairness in the capital markets. However, the component parts of SROs-member firms-have quite divergent interests from the public.").
Member firms-or "Specialist Firms"-are the entities on the stock exchange floors that actually execute sales and purchases of securities for investors. The NYSE has seven member firms through which all securities on the exchange are bought and sold. The member firms are for-profit entities that are allowed to keep an inventory of stock for themselves to sell when a purchase order lacks a ready seller. See In re NYSE Specialists Sec. Litig., 503 F.3d 89, 91-92 (2d Cir. 2007). The facts of In re NYSE Specialists Securities Litigation demonstrate the intricate ways that member firms have manipulated the market to their own advantage. See infra Part II.
For a historical perspective of SRO scandals that have led to heightened SEC regulation, see Friedman, supra note 58, at 746-50.
[Vol. 94:415 member's business. 63 Conversely, an SRO's for-profit status may create an incentive to over-regulate because the fines SROs levy against their members go directly into their coffers, providing immediate revenue.
6 4 E. The 1975 Amendment to the Exchange Act These inherent deficiencies in the self-regulatory system led Congress to strengthen the SEC's authority over the SROs via the 1975 amendments to the Exchange Act. 65 The amendments allowed the SEC to enforce the SROs' own rules in situations where the SROs were reluctant or unable to do so. 66 The result was a more powerful SEC with authority over SRO rulemaking and SRO disciplinary actionand an SEC that, perhaps most importantly, can discipline the SROs themselves for their actions or failures to act. In 2007, two of the most prominent SROs-the NASD and the NYSE-decided to change their regulatory structure. 68 They combined many of their member-regulation functions into a new entity called the Financial Industry Regulatory Authority (FINRA).69 FINRA now oversees the SROs' broker-dealer regulatory functions, though the SROs maintain regulatory control of their own markets. 70 With this move, the SROs essentially separated their market function from 63 Fleckner, supra note 10, at 2593-94. 64 Id. at 2594-95 (noting that this type of overregulation would be problematic because it would not be driven by the SRO's regulatory standards, but rather its financial goals). John Carson discusses proposed strategies to manage these conflicts of interest:
Exchanges and regulators have employed a range of responses in order to manage conflicts of interest. While the specific mechanisms vary widely, responses fall into the following general categories: " Enhance corporate governance requirements " Impose ownership restrictions " Reinforce exchange's public interest mandate " Upgrade supervision by regulator " Strengthen exchange internal controls and management processes " Transfer regulatory functions to an independent SRO " Transfer regulatory functions to the Public Regulator. See Carson, supra note 26, at 3. most of their regulatory functions, 7 ' making their status as for-profit entities even clearer.
Although FINRA now controls much of the SROs' regulatory function, the discussion that follows-on SROs' absolute immunity for activities that take place within their regulatory authority-is still highly relevant for two reasons. First, Weissman and the other cases discussed above predate FINRA. Second, these cases address the scope of the absolute immunity that SROs are granted as regulators of their own markets (rather than regulators of their members) -a role that both NASDAQ and the NYSE maintain.
F. Absolute Immunity
By regulating their own markets, SROs perform the quasi-governmental function that affords them absolute immunity from private lawsuits (so long as their activities fall within that regulatory function).73 Through self-regulation, SROs act for the SEC, which would otherwise regulate the securities markets-and would be afforded sovereign immunity for doing so. 74 Because SROs are private entities, they do not enjoy sovereign immunity; rather, they enjoy what is (somewhat misleadingly) termed "absolute immunity," an idea that stems from sovereign immunity. 75 The SRO stands in the shoes of the SEC in interpreting the securities laws for its members and in monitoring compliance with those laws. It follows that the [SRO] should be entitled to the same immunity enjoyed by the SEC when it is performing functions delegated to it under the SEC's broad oversight authority. The term "absolute immunity" is a bit misleading because SROs "do not enjoy complete immunity from suits; it is only when they are acting under the aegis of the Exchange Act's delegated authority that 71 Id. he NYSE, when acting in its capacity as a SRO, is entitled to immunity from suit when it engages in conduct consistent with the quasi-governmental powers delegated to it pursuant to the Exchange Act .... "). Such immunity from private suit is not specific to securities exchanges. Sovereign immunity (from which absolute immunity for SROs derives) protects the federal government against civil suit or criminal prosecution; judicial immunity is granted to judges when acting in their official capacity; and prosecutorial immunity allows prosecutors to grant witnesses immunity from prosecution of their crimes in exchange for their testimony. See Clinton v.Jones, 520 U.S. 681, 693 (1997) ("In cases involving prosecutors, legislators, and judges we have repeatedly explained that the immunity serves the public interest in enabling such officials to perform their designated functions effectively without fear that a particular decision may give rise to personal iiabiiity. and publicly announces regulatory decisions. 8 5 A common theme is that absolute immunity attaches in cases that involve the "proper functioning of the regulatory system. The complaint alleged that the point of the advertisement was to promote those companies as the world's most successful and sought af-90 Throughout the complaint, Weissman referred to NASDAQ as "The For Profit," id. at 1298 n.5, presumably to drive home the point that NASDAQ sought monetary gain for the benefit of its shareholders from its promotion of WorldCom and was thus outside its quasi-governmental regulatory authority. 
95
Complaint, supra note 91, 6. 96 Weissman, 500 F.3d at 1298-99.
97
Id. at 1298. 98 Id. at 1298-99.
ter, 9 9 yet the ad did not communicate-nor did Mr. Weissman allege that it communicated-that WorldCom specifically was a good investment. 1 0 0 NASDAQ's second public statement upon which Mr. Weissman claimed reliance was a two-page Wall Street Journal spread, whose purpose (according to Mr. Weissman) was to "calm the markets in the wake of [the] Enron fraud."' 1 1 The spread publicly communicated some of NASDAQ's financial disclosure standards established by the SEC-particularly, that NASDAQ-listed companies should follow Generally Accepted Accounting Principles (GAAP). 10 2 It also included a section with the slogans "The Responsibilities We All Share," "Keeping Our Markets True-It Is All About Character," and "Our Beliefs Stand In Good Company," under which appeared a list of chief executives whose companies traded on the NASDAQ exchange, including Bernard Ebbers of WorldCom.1 0 3 The ad did not mention WorldCom specifically, other than to say that it was among those companies that met the listing criteria.1 0 4 Mr. Weissman claimed that he relied on this advertisement-specifically, that it was evidence of NASDAQ's endorsement of WorldCom as a company of good character and responsible accounting-when he purchased additional shares the day after The Eleventh Circuit convened en banc "to address the question of whether [an SRO] . . . enjoys absolute immunity for the advertisements described in the complaint in this case."' 1 6 In a notably short majority opinion, the court held that because SROs may claim absolute immunity only when performing functions delegated by the Exchange Act, and because the advertisements upon which Mr. Weissman allegedly relied "were in no sense coterminous" with those regulatory functions, the district court appropriately denied absolute immunity.
1 0 7
A. In re NYSE Specialists Securities Litigation
On the very same day that Weissman was decided, the Second Circuit upheld the NYSE's absolute immunity against allegations that it failed to properly regulate its Specialist Firms, through whom all buy-
99
Id. at 1299.
100
Id. at 1313 (Tjoflat,J., dissenting).
101
Id. at 1299 (majority opinion) (citing Complaint, supra note 91, 62).
102
103
Id.
104
Id. at 1313 (Tjoflat, J., dissenting).
105
Id. at 1299 (majority opinion).
106
Id. at 1295.
107
ers ). Prior to the Lead Plaintiffs' class action suit, the SEC invoked its own regulatory authority against the Specialist Firms. This resulted in settlement agreements under which the firms admitted that they had failed to maintain a fair and orderly market but did not admit to specific Exchange Act violations. The SEC also simultaneously filed and settled an enforcement action against the NYSE, whereby the NYSE did not admit to specific violations but agreed to an order that imposed a censure and prevented the NYSE from committing future federal securities violations. Id. at 94.
109
To grasp the full breadth of the Second Circuit's interpretation of the NYSE's regulatory authority, one must first understand the procedure that NYSE members must follow to buy and sell stocks. Each security traded on the exchange is assigned to a particular Specialist Firm, through which buyers present offers to buy and sellers present offers to sell that security. Each Specialist Firm has an electronic "display book," which allows them to execute orders received from the market to buy and sell. The Specialist Firms act as agents for buyers and sellers by executing orders to buy and sell at the same price. Buyers and sellers are not allowed to conduct trades on the trading floor without the Specialist Firms. ld. at 92.
The Specialist Firms are also permitted to act as principals, in a limited fashion. For instance, when there are no orders to buy and sell at the same price, the Specialist Firms may execute an order to buy by selling from the Firm's own inventory of such stock, or execute an order to sell by buying the stock and adding it to the Firm's inventory. See id. The complaint points out that the Specialist Firms are in a unique position as potential buyers and sellers that not only control trade but have superior, non-public information about the supply and demand of a given stock. Id. at 93-94.
110 Id. at 93-94. Specifically, the Lead Plaintiffs accused NYSE of ignoring, concealing, and encouraging the Specialist Firms' following violations: (1) "interpositioning"-preventing a trade between a normal buyer and seller, to its own benefit; (2) "trading ahead"-using its information to execute trades for its own account ahead of public investors in order to benefit from the gain or loss that the public investors' subsequent trades would create in the market; (3) "freezing the book"-halting the display book for a certain stock to trade from its own inventory before public investors could make any orders; and (4) "manipulating the tick"-changing the price of a stock to affect trading. Id. at 93. .pre-rclcasc allcgcdly stated, "Our agency-auction model joins the greatest liquidity and transparency with the most efficient method of price discovery, leading to the lowest execution costs and best prices for consumers." Id. at 94. NYSE's reliability and integrity.
11 3 In describing the fraudulent misrepresentation section of the complaint, the court states that Lead Plaintiffs claim that these statements deliberately created "the false impression that [the Exchange] was overseeing and operating its auction market in accordance with laws, rules and regulations, and l[ed] investors to believe that the NYSE was an honest and fair market," and that they relied on these misstatements in trading stocks listed on the NYSE's exchange during the Class Period.
114
The Southern District of New York granted the NYSE's motion to dismiss for failure to state a claim because the NYSE is an SRO and, as such, enjoys absolute immunity as the allegations arose out of the NYSE's quasi-governmental regulatory authority.
1 15 Alternatively, the district court granted the NYSE's motion to dismiss because the Lead Plaintiffs lacked standing to pursue their fraudulent misrepresentation claim.' 16 The Second Circuit affirmed the district court's grant of absolute immunity but vacated the denial of Lead Plaintiffs' standing. 117 The court did not address whether the alleged misrepresentations related to the NYSE's for-profit or regulatory function 1 8 but specifically directed the district court to consider whether the Lead Plaintiffs' reliance on the statements caused their losses.
19
By affirming the district court's ruling that the Lead Plaintiffs' claims were barred by absolute immunity, the Second Circuit explicitly interpreted the NYSE's regulatory authority to include the announcement of the SEC investigation and the approval of regulatory reports on its exchange floor. 120 Perhaps most importantly, however, the court unambiguously declined to carve out a fraud exception from the doctrine of absolute immunity, noting that even an exception for the most egregious instance of fraud would undermine the
113
One such advertisement included then-Chairman of the NYSE, Richard Grasso. Id.
114
Id. at 94-95.
115
Id. at 90-91, 99.
116
Id. at 91.
117
Id. at 102. The district court dismissed the case in part because it interpreted Rule 10b-5 to say that an action for false statements about a security applies only to the issuer of the security. Id. The Second Circuit disagreed, and remanded for further argument on the misrepresentation claims. Id. at 102-3. However, the Second Circuit tipped its hand by noting that at least one potential theory of reliance-the fraud-on-the-market theory, under which "the misrepresentation itself affects the market price of the security purchased"-would probably not apply. Id. at 103.
118
Id. at 103; Karmel, supra note 27, at 8. 119 In re NYSE Specialists, 503 F.3d at 102-3. 120 Id. at 100 ("The gravamen of the Lead Plaintiffs' claims, however, centers on the functions performed by NYSE in its supervisory and regulatory role: announcing investigations, signing off on regulatory reports on the stock exchange floor, and examining the Form 81s for content and legality. While these actions may not appear to form the heart of the regulatory functions delegated to the NYSE as an SRO, they are nonetheless central to effectuating the NYSE's regulatory decisionmaking.").
[Vol. 94:415 purpose of the doctrine-to free SROs' quasi-governmental function from disruptive litigation. The remand sets up an emerging circuit split should the Second Circuit rehear the fraudulent misrepresentation argument on appeal and hold fast to their grant of absolute immunity to the NYSE. But even without the fraudulent misrepresentation analysis, the Second Circuit has clearly adopted a broader view of absolute immunity for SROs than the Eleventh Circuit. The Eleventh Circuit withheld NAS-DAQ's absolute immunity for what was arguably a regulatory function-publicly communicating its capabilities and regulations.' 2 2
Meanwhile, the Second Circuit declined to carve out a fraud exception to absolute immunity for a highly publicized, 1 23 SEC-investigated 1 24 fraud that allegedly went on at a high level inside the NYSE for a number of years, 125 simply because the fraud occurred within the SRO's regulatory function.
6
The difference in the analyses of the two cases lies in the way each court views the scope of an SRO's regulatory function. The Second Circuit, although reserving judgment on the public statement aspect of the complaint, views SRO regulatory authority broadly, so as to include all of the NYSE's other alleged misconduct. 127 On the other hand, the Eleventh Circuit views that regulatory function narrowly, so as to not even include a public statement intended to communicate the SRO's standards if that statement in any way mentions a company that trades on its exchange. 128 Weissman's narrow approach to an SRO's regulatory authority (and thus absolute immunity) may make Weissman an untenable precedent. 
125
In re NYSE Specialists, 503 F.3d at 94. 126 Id. at 97 (" [T] o the extent that this concept was unclear in our prior precedent, we make thc assertion plain: If an SRO's exercise of a governmental power delegated to it deserves absolute immunity, the SRO's nonexercise of that power also entitles it to immunity.").
127
Id. at 102.
128
Weissman v. Nat'l Ass'n of Sec. Dealers, 500 F.3d 1293, 1299 (11th Cir. 2007).
B. Opulent Fund v. NASDAQ Stock Market Follows Weissman's
Narrow Approach Another court has already followed the Weissman precedent to some extent. In Opulent Fund v. NASDAQ Stock Market-yet another case where an SRO made a public statement that threatens to expose it to liability-the Northern District of California drew heavily from Weissman when it denied NASDAQ's motion to dismiss for absolute immunity.
129
The Plaintiffs-Opulent Fund, L.P. and Opulent Lite, L.P. (Opulent)-were private investment partnerships that profited from trading in stock index options. 1 30 The value of the NASDAQ-100 Index directly impacted the profits or losses realized on certain options that Opulent traded. 1 31 (The options were thus derivatives of the NAS-DAQ-100 Index.) 1 32 The value of the NASDAQ-100 Index depends on the value of the individual securities on the Index, or more precisely, the NASDAQ Official Opening Price (NOOP) of each security in the Index; thus, timely and accurate reporting of the NOOP and the NASDAQ-100 Index price was essential to Opulent's option trading. 133 Opulent alleged that on May 19, 2006, NASDAQ reported a NAS-DAQ-100 Index price of $1,583.45, while calculating the price based on the NOOPs of the underlying stocks should have yielded a price of $1,589.18.134 According to Opulent, the error of $5.73 per share resulted in significant losses.1 35 The court quoted Weissman in denying NASDAQ's motion to dismiss and characterized NASDAQ's statement not as regulatory, but rather as within its private, for-profit capacity: "A] s a private corporation, NASDAQ may engage in a variety of nongovernmental activities that serve its private business interests, such as its efforts to increase trading volume."' 136 The court found unpersuasive NASDAQ's argument that the SEC approved the very formula that generated the price later disputed by Opulent. 
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Id. at *1.
131
Id. The NASDAQ-100 Index includes the one hundred largest non-financial securities that trade on NASDAQ's exchange. The index is weighted by the market value of the securities of the index, using an SEC-approved computational method. Id.
132
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134
135 Id. That difference cost Opulent significantly on short-put option contracts when Opulent was forced to buy back the security at the strike price of $1,590. Id.
136
Id. at *5 (quoting Weissman v. Nat'l Ass'n of Sec. Dealers, Inc., 500 F.3d 1293, 1296 (1Ith Cir. 2007)). 137 Id. (emphasizing that engaging in regulatory conduct, and not SEC approval, is the "sine qua non of SRO immunity").
Although Opulent Fund does not involve an SRO's advertising through a public medium, as Weissman did, certain similarities between the cases indicate that Opulent Fund may narrow SRO immunity even further. First, Opulent's allegation involves an SRO making a public statement-that the NASDAQ-100 Index price was what NAS-DAQ said that it was.' 38 However, in Opulent Fund, the public statement was not even arguably an attempt to induce investors; rather, the announcement of its NOOP was simply part of its daily operations. The court argued that because the NASDAQ-100 Index is intended to facilitate and support derivative trading-which is not something the government would do if it were performing the SRO's duties-that the NASDAQ-100 Index was not part of NASDAQ's quasi-governmental regulatory function.
13 9
Second, the Opulent Fund court uses an underlying theme from Weissman-that an SRO's for-profit status tends to weigh against an argument that the SRO was acting within its regulatory authority40 -to deny absolute immunity. That is, because NASDAQ sought to create a derivative market as a way to profit, 14 1 NASDAQ "represents no one but itself."' 14 2 Accordingly, NASDAQ should not be granted absolute immunity for an action that is not quasi-governmental. 43 The
Opulent Fund court thus follows Weissman in weighing NASDAQ's forprofit status heavily when determining whether the activity complained of was indeed "regulatory" and whether immunity should attach. 144 Third, Opulent Fund may undermine the doctrine of absolute immunity even further by following Weissman's narrow, pro-plaintiff approach to the pleadings' stage to judge whether immunity is or is not appropriate. Never is this more obvious than where the Opulent Fund
138
139
Id. at *5 (distinguishing NASDAQ's actions from what the court considers an SRO's regulatory functions, such as suspending trading, banning traders, and carrying out disciplinary actions). 140 Weissman, 500 F.3d at 1299 ("Even if NASDAQ's status as a money-making entity does not foreclose absolute immunity for any number of its activities, its television and newspaper advertisements cannot always be said to directly further its regulatory duties under the Securities Exchange Act. These advertisements-by their tone and contentwere in the service of NASDAQ's own business, not the government's, and such distinctly non-governmental conduct is not protected by absolute immunity."); Opulent Fund, 2007 WIL 3010573, at *5.
141
NASDAQ profits by selling the market price data to investors. See Opulent Fund, 2007 WArL 3010573, at *5. 142 Id. at *5 (quoting Weissman, 500 F.3d at 1299).
143
See id. at *5. 144 Id. ("NASDAQ's duty to accurately calculate and disseminate an index price does not function to protect investors; instead, NASDAQ's actions function to create a market and increase trading."). But see id. at *5 n.1 ("That NASDAQ happens to profit from its activities is not critical. The immunity inquiry turns on the nature of the challenged conduct.").
court quotes Weissman in stating that "'grants of immunity must be narrowly construed' because they deprive injured parties of remedies."
145

III ANALYSIS AND IMPLICATIONS OF WEISSMAN
Weissman is problematic for several reasons. First, by allowing Mr. Weissman to plead around NASDAQ's absolute immunity defense, the Eleventh Circuit undercuts the very purpose of the absolute immunity doctrine: to cut off a claim at the pleadings' stage so officials performing important duties may have the peace of mind to focus on those duties. 14 6 Second, Weissman narrows SRO regulatory authority by overlooking an Exchange Act purpose that NASDAQ's advertisements served: "to remove impediments to and perfect the mechanism of a free and open market."'1 47 Third, Weissman chills the use of public media for SRO communications.
A. Weissman Undercuts the Purpose of Absolute Immunity for SROs
The purpose of absolute sovereign immunity is to afford government officials the discretion to perform their duties without the distraction of ongoing and recriminatory litigation.' 48 Absolute immunity for SROs is intended to serve the same purpose when SRO officials are performing quasi-governmental functions. 149 Pretrial discovery is just the type of distraction that absolute immunity is meant to avoid; 150 so the very purpose of absolute immunity is defeated if it is not applied aggressively at the pleadings' stage, before discovery begins. 15 1 Applying absolute immunity at the pleadings' stage requires a
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Id. at *5 n.2 (quoting Weissman, 500 F.3d at 1297). 146 In re NYSE Specialists Sec. Litig., 503 F.3d 89, 97 (2d. Cir. 2007); Barbara v. NYSE, 99 F.3d 49, 59 (2d. Cir. 1996) (explaining that Congress's purpose in enacting the Exchange Act would be hindered by suits arising out of SRO's quasi-governmental functions).
15 U.S.C. § 78o-3(b)(6) (2006). 148
In re NYSE Specialists, 503 F.3d at 97, 101; Barbara, 99 F.3d at 58-59 (noting that absolute immunity is particularly appropriate in the SRO context because the SEC would be afforded sovereign immunity if it were to carry out those same functions). 149 In re NYSE Specialists, 503 F.3d at 97 ("After all, the purpose of immunity is to give governmental officials-or those acting with the express delegation of the government, as with SROs-breathing room to exercise their powers without fear that their discretionary decisions may engender endless litigation."); cf Imbler v. Pachtman, 424 U.S. 409, 424-25 (1976) (addressing absolute immunity for prosecutors). court to glean from the complaint the plaintiffs "precise claim." 15 2
Only after determining that "precise claim" may the court decide whether the activity complained of is one to which absolute immunity attaches.
53
The Weissman court failed to determine Mr. Weissman's precise claim and instead allowed Mr. Weissman to artfully plead around NASDAQ's absolute immunity defense. In his complaint, Mr. Weissman alleged-and the court majority parroted-that "NASDAQ touted, marketed, advertised and promoted WorldCom, falsely representing it as a good company and worthwhile investment and disseminating its fraudulent financial statements, without revealing that, inter alia: . . . WorldCom was not in compliance with N[ASDAQ] listing requirements .. . .,,54 From that statement, it appears that Mr. Weissman's precise claim is that NASDAQ's for-profit status caused it to continue listing WorldCom even after it knew or should have known that NASDAQ was acting illegally. 155 But such an allegation would not have evaded NASDAQ's absolute immunity because the decision to list or not list a stock clearly falls within NASDAQ's regulatory authority. In dissent, Judge Tjoflat pointed out that the majority accepted these conclusory statements without questioning their veracity. How Mr. Weissman could have known exactly whether the NASDAQ regulatory or for-profit function persuaded him to purchase shares of WorldCom is perplexing, but the court appears to take Mr. Weissman at his word that his reliance was beyond NASDAQ's regulatory authority. Had the court probed more closely to determine Mr. Weissman's precise claim, the outcome would likely have been different.
Mr. Weissman's precise claim was based on the two advertisements described above. The first--the television ad for NASDAQ's 100 Index Trust-featured a group of one hundred companies that had the largest market capitalizations, including WorldCom.1 59 But that television ad did not tout WorldCom specifically as a good investment 1 60 or distinguish it in any way from the other ninety-nine companies mentioned 161 -none of which were purchased by Mr. Weissman right away as a result of it. His precise claim with respect to this ad is simply that NASDAQ ran a commercial that listed WorldCom among the one hundred companies with the largest market capitalizationshardly the aggressive marketing of WorldCom and upon which Mr. Weissman claims reliance.
The Wall Street Journal spread was even less suggestive. The ad expressed NASDAQ's belief that companies that list on its exchange should report their financials accurately, using GAAP. 1 62 It included a list of chief executives of companies that trade on the NASDAQ exchange, 1 63 which happened to include Bernard J. Ebbers, WorldCom's president and CEO,1 64 along with the names of eightyone chief executives of other companies.1 65 The inclusion of Mr. Ebbers's name on that list, however, was apparently such an effective marketing technique that it alone-not any of WorldCom's perceived qualities-caused Mr. Weissman to purchase additional shares the very next day, even as WorldCom's share price plummeted.
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Weissman, 500 F.3d at 1312 (Tjoflat,J., dissenting) ("[Tlhe majority all too happily accepts Weissman's baseless disavowal of 'any reliance on NASDAQ's regulatory activity as the basis for his suit,' . . . apparently taking his word for it that NASDAQ's actions constituted touting, marketing, advertising and promotion and that such activities fall outside the functions for which NASDAQ ought to enjoy immunity.").
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Id. at 1298-99 (majority opinion).
160
161
162
Id. at 1301 (Pryor, J., concurring in part and dissenting in part).
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Brief for Defendants-Appellants at 9, Weissman v. Nat'l Ass'n of Sec. Dealers, No. [Vol. 94:415
Mr. Weissman's highly unusual reaction to a rather passive advertisement led the court to again mischaracterize his precise claim. Its more accurate characterization is that NASDAQ ran an ad dispatching its regulatory information, intending to convey no more than that NASDAQ-traded companies must meet strict listing requirements, and that WorldCom was among the companies traded on NASDAQ's exchange.
1 See, e.g., Weissman, 500 F.3d at 1296 (majority opinion).
171
Id. at 1296.
172
Id. at 1300-02 (Pryor, J., concurring in part and dissenting in part).
nism of a free and open market and a national market system, and, in general, to protect investors and the public interest ....
173
To accomplish these goals, an SRO must have authority to list and de-list the securities that trade on its exchange. 174 Thus, the communication of the listing requirements used to determine whether a security is listed or de-listed must also be considered a regulatory function. 175 Such information is essential for listed companies to know how to remain in compliance with listing requirements and for the investing public to know what standards those traded companies must meet. As such, this function properly falls under an SRO's delegated regulatory authority "to remove impediments to and perfect the mechanism of a free and open market."'1 76
The Weissman court seems to have overlooked the regulatory purpose served by the Wall Street Journal advertisement. The result is a narrower view of an SRO's regulatory authority, which carves out a significant chunk of the doctrine of SRO absolute immunity. After Weissman, an SRO may be subject to liability if it publicly communicates its listing requirements alongside a list of companies that the SRO believes to meet those requirements.
C. Weissman Chills SRO Media Communications
Another negative implication of Weissman is that SROs will now be more reluctant to use commercial media outlets to communicate their regulatory standards to the investing public. Mr. Weissman's complaint seized on the bare mention of WorldCom's CEO, Bernard Ebbers, in a newspaper spread intended to communicate NASDAQ's listing requirements.
177 Such a statement, which was once a permissible form of public communication from SROs to shareholders, listing companies, and potential investors, could now render SROs liable for the fraudulent actions of any and all companies that trade on their exchanges. A perception of certain types of advertisements-such as 
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See DL Capital Group v. NASDAQ Stock Mkt., 409 F.3d 93, 98 (2d Cir. 2005) (finding an SRO immune after it announced the suspension of trading, which the court likened to the regulatory action of actually suspending trading).
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15 U.S.C. § 78o-3(b) (6); see DL Capital Group, 409 F.3d at 98 ("'Without the capacity to make announcements, [SROs] would be stripped of a critical and necessary part of their regulatory powers'-namely, the power to inform the public of those actions it has undertaken in the interest of maintaining a 'fair and orderly market' or protecting 'investors and the public interest."' (quoting NASD Rule 11890(b) (2008))); see also Weissman, 500 F.3d at 1301 (PryorJ., concurring in part and dissenting in part) (describing an SRO's right to communicate to the investing public that listed companies must satisfy rigorous financial standards).
177
Complaint, supra note 91, 62.
[Vol. 94:415 those in Weissman-as beyond the scope of an SRO's regulatory function will foster distrust of public media as an avenue for such communication and frustrate an SRO's ability to communicate publicly with shareholders.
One might argue that an SRO could avoid such potential liability by simply removing the names of any companies that trade on that exchange from its public statements. But the Weissman court did not draw a line there, or anywhere, to indicate the extent to which an SRO may tout its services through public statements without risking liability. The cursory majority opinion seems to stand for the proposition that any mention of a company by an SRO represents the SRO's whole-hearted endorsement of that company's professional integrity; the SRO will not be able to claim immunity if that company turns out to have acted fraudulently.
Similarly, with respect to the forms of public statements that will preclude an absolute immunity defense, Weissman leaves more questions than it answers. Does Weissman mean that an SRO forfeits its absolute immunity when using its website to list certain companies that trade on the exchange? May an SRO executive speak to the quality of the exchange in a speech or an interview by mentioning the specific companies that trade on it? Does the SRO expose itself when using the Wall Street Journal to disseminate other types of regulatory information, such as suspension or resumption of trading notices? 178 Must SROs find a way to demonstrate their value without mentioning those companies at all? The lack of answers to these pivotal questions will leave SROs wondering which forms of communication will cause them to forfeit their absolute immunity and which will not. The result will likely be a decrease in the use of the commercial media as an outlet for SRO communications. The current test for absolute immunity leaves too much room for courts to interpret whether a public statement qualifies as a quasi-governmental regulatory function. 179 As a result, the SROs' ever-increasing for-profit status is swaying courts away from granting SROs absolute immunity for their public statements.
A better approach would be to categorize an SRO's public statements as either purely regulatory, purely nonregulatory, or mixed, before determining whether absolute immunity should attach. Purely regulatory statements, such as disclosures of listing requirements that do not mention any companies specifically, should always enjoy abso-lute immunity. Purely nonregulatory statements, such as naked promotion of companies that trade on an SRO's exchange (or naked promotion of the exchange itself), should never enjoy absolute immunity. Mixed statements, however, present a trickier question, to which the Weissman court neglected to respond with a clear legal standard.
Mixed statements, the broad category that would seem to include the advertisements in Weissman, contain some regulatory information and some other information that serves little regulatory purpose. This other information may run the gamut of everything that an SRO wishes to convey and may span the full range of an SRO's authority spectrum-from regulatory to for-profit. An SRO's immunity with regard to mixed statements should thus turn on the nature of the information and whether the information serves little regulatory purpose. The best approach to determine the nature of the information in mixed statements is an "investment recommendation" test: if the information is neutral, in that it simply provides names of companies and their CEOs, for instance, absolute immunity should attach; on the other hand, if the statement makes an explicit or implicit recommendation for a particular course of investment, 80 an SRO should forfeit its absolute immunity. In other words, an SRO's regulatory authority includes the broad authority to make public statements, unless the statement recommends a particular course of investment. If instead an SRO's public statement does recommend a particular investment, the SRO's absolute immunity should not bar a claim if an investor relies upon and is injured by the statement. Recommending a particular course of investment is clearly beyond what the SEC would do and what an SRO should do. . When determining whether an SRO's public statement recommends an investment, courts should consider the following factors: the quantity of regulatory information in proportion to the other information included in the statement; the sophistication of the investor (or potential investor) at whom the statement is targeted; the truth of the statement; the font size of the information in question in relation to the statement's regulatory information; whether the statement is made by an individual officer to a particular audience or as a generic statement from the SRO to the investing public at large; the medium through which the statement is made; and whether the information is intended to be relied upon as investment advice or should be dis-missed as puffery.
1 " A final consideration may be the economic context in which the statement is released-during periods of financial crisis, investors may be hyper-sensitive to positive information and thus more likely to perceive mixed SRO statements as investment recommendations. No single factor will likely dominate the analysis; courts should adjust the relative weight of these factors in each particular case.
E. Reexamining the Case Law Under the New Approach
A reexamination of Weissman under this standard would yield quite a different result. The following factors tend to indicate that the advertisements in Weissman did not recommend a particular course of investment: (1) the regulatory information in both advertisements dwarfed NASDAQ's mere mention of WorldCom; (2) the non-regulatory information in both advertisements was true-WorldCom was listed on NASDAQ and Bernard Ebbers was indeed its CEO; (3) the advertisements were targeted at the investing public at large through commercial media (rather than, say, a live speech by a corporate officer to a limited number of individuals); and (4) the slogans contained in the statements were highly generic in nature, Opulent Fund would be even more likely to come out differently under this investment recommendation test.1 8 4 NASDAQ's statement announcing the price of its index would likely fall into the purely regulatory category of SRO public statements, since NASDAQ simply announced the price of its NASDAQ-100 Index and did not include any
181
See In re Ford Motor Co. Sec. Litig., 381 F.3d 563, 570-71 (6th Cir. 2004) ("Courts everywhere 'have demonstrated a willingness to find immaterial as a matter of law a certain kind of rosy affirmation commonly heard from corporate managers and numbingly familiar to the marketplace-loosely optimistic statements that are so vague, so lacking in specificity, or so clearly constituting the opinions of the speaker, that no reasonable investor could find them important to the total mix of information available."' (quoting Shaw v. Digital Equip. Corp., 82 F.3d 1194, 1217 (1st Cir. 1996))); see also Lasker v. N.Y. State Elec. & Gas Corp., 85 F.3d 55, 58 (2d Cir. 1996) (affirming the district court's assertion that a corporation's self-praise about its business strategy is "not considered seriously by the marketplace and investors in assessing a potential investment").
182
See supra Part II. other information in the statement that could possibly be interpreted as recommending a particular investment. It is, however, unclear whether In re NYSE Specialists Securities Litigation would come out differently. The Second Circuit's opinion 1 8 5 does not provide enough details of the NYSE's public statements concerning the quality of its oversight function to determine whether it recommended a particular course of investment.
CONCLUSION
In viewing an SRO's regulatory duties narrowly and allowing Steven Weissman to artfully plead reliance on NASDAQ's for-profit capacity, the Eleventh Circuit undermined the doctrine of absolute immunity for SROs. In denying NASDAQ's motion to dismiss, the court defeated the doctrine's purpose and exposed SROs to liability from individual investors. The Eleventh Circuit's narrow approach to absolute immunity is vastly dissimilar to that of the Second Circuit, which declined to carve out an exception to absolute immunity even when faced with allegations of egregious fraud that went on for years, cost investors millions, and warranted SEC action.
The negative implications of Weissman are as follows: the decision (1) allows investors to plead around an SRO's absolute immunity by simply claiming reliance solely on its for-profit function; (2) limits SRO's legitimate behavior because they do not know beforehand what conduct falls under their regulatory authority and what does not, making it much harder for absolute immunity to serve its essential purpose; and (3) chills SRO communications through public media.
If the Second Circuit has the opportunity to revisit the fraudulent misrepresentation claim from In re NYSE Specialists Securities Litigation on appeal from remand, it should expressly decline to follow any Weissman-like narrowing of the doctrine of absolute immunity for the reasons set forth above. Further, if the Ninth Circuit has an opportunity to hear Opulent Fund on appeal, it should decline to follow Weissman and reverse.
Perhaps a better approach to SRO absolute immunity for public statements is to ask whether the statement recommends a particular course of investment. If not, SROs should maintain their absolute immunity from private lawsuits.
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